Prot# VMNHU-003: A Phase III, Double-Blind, Randomized, Placecontrolled, Multicenter Study to Assess the Safety and Efficacy of VM202 to Treat Chronic Nonhealing Foot Ulcers in Diabetic Patients with Concomitant Peripheral Arterial Disease (PAD)

Project: Research project

Project Details

StatusFinished
Effective start/end date8/4/17 → 8/4/20

Funding

  • SynteractHCR, Inc. (VMNHU-003 // VMNHU-003)
  • ViroMed Co., Ltd. (VMNHU-003 // VMNHU-003)